ANI Pharmaceuticals ANIP Asset turnover

Asset turnover at other companies

Amneal Pharmaceuticals, Inc.AMRX

0.9×0.0×

ViatrisVTRS

0.4×+0.1×

AnaptysBio, Inc.ANAB

0.6×+0.3×

ALN

Alnylam PharmaceuticalsALNY

0.9×+0.4×

Eton Pharmaceuticals, Inc.ETON

1×+0.1×

Aurinia PharmaceuticalsAUPH

0.5×0.0×

FAQ

What is ANI Pharmaceuticals's asset turnover?

ANI Pharmaceuticals (ANIP) reported asset turnover of 0.7× in Q2 2026.

How has ANI Pharmaceuticals's asset turnover changed year-over-year?

ANI Pharmaceuticals's asset turnover increased by 4.5% year-over-year, from 0.7× to 0.7×.

What is the long-term trend for ANI Pharmaceuticals's asset turnover?

Over 5 years (2020 to 2025), ANI Pharmaceuticals's asset turnover has grown at a 7.4% compound annual growth rate (CAGR), from 0.5× to 0.6×.

What does asset turnover mean?

Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.